- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Plexus Corp(PLXS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PLXS
11/13/2026: PLXS (3-star) is currently NOT-A-BUY. Pass it for now.
Plexus Corp is a prominent provider of complex product realization services, specializing in engineering, manufacturing, and support for high-regulation sectors like healthcare and industrial technology. The company distinguishes itself through a focus on high-complexity, high-reliability products rather than high-volume consumer goods, which has historically helped it build deep relationships with long-term customers. While it has a leading position in its niche, the stock is subject to industrial cyclicality and customer concentration risks. Plexus does not pay a dividend, making it better suited for growth-oriented investors looking for exposure to the medical and industrial automation sectors. Key developments to monitor include customer program wins and the progress of its manufacturing expansion in the Americas.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Plexus targets high-growth segments in medical and industrial technology which provides a long runway for expansion. |
| Momentum investor | Strong fit while signal remains positive | The stock often trends with successful contract wins and positive earnings momentum in the industrial sector. |
| Value investor | Mixed fit | Valuation often tracks closely with industrial manufacturing cycles, making entry point timing important. |
| Dividend investor | Weak fit | Plexus does not pay a dividend, prioritizing internal growth reinvestment. |
| Low-risk investor | Mixed fit | While established, the stock is subject to industrial cyclicality and customer concentration risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock can experience swings based on quarterly earnings results and general industrial sector sentiment. |
| Valuation risk | Medium | Market expectations for growth in medical and aerospace can lead to premium pricing during sector rallies. |
| Competition risk (EMS market competition) | Medium / high | Plexus faces intense competition from both massive global EMS players and specialized regional firms. |
| Business quality | Medium | The business model relies on high-complexity, high-regulation products which requires significant engineering competence. |
| Dividend income | Low / none | Income-focused investors will find no yield here as the company reinvests all free cash flow. |
| Execution risk | Medium | Delivering complex products on time for regulated industries requires flawless manufacturing and supply chain coordination. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.56B USD | Price to earnings Ratio 28.13 | 1Y Target Price 307.8 |
Price to earnings Ratio 28.13 | 1Y Target Price 307.8 | ||
Volume (30-day avg) 313.9K shares | Beta 0.96 | 52 Weeks Range 132.03 - 307.06 | Updated Date 11/14/2026 |
52 Weeks Range 132.03 - 307.06 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 7.41 |
Sector & Industry Intelligence
Sector
Technology
Caution- Sentiment
- Near Bearish
- Momentum
- Rapid Breadth Deterioration
- BUY participation
- 30.1%
- Active BUY / eligible
- 37 / 123
- 30-Day BUY Count Change
- -42
- Market state
- Weak Bullish / Near Bearish
BUY participation is falling rapidly, suggesting elevated market vulnerability.
Industry
Electronic Components
- BUY participation
- 0.0%
- Active BUY / eligible
- 0 / 11
- 30-Day BUY Count Change
- -6
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 24.48% | Avg. Invested days 49 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Healthcare / Life Sciences | Manufacturing for surgical robotics, diagnostic systems, and life-critical patient monitoring devices. | This is a stable, high-margin sector with long-term client commitments. |
| Industrial / Commercial | Hardware for automation, environmental monitoring, and smart facility management. | Highly sensitive to macroeconomic industrial capital expenditure trends. |
| Aerospace / Defense | Highly reliable electronic components for defense and aerospace platforms. | Provides long-term project visibility but requires stringent government compliance. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-28 | When After Market | Estimate 2.26 | Actual 2.51 |
Profitability
Profit Margin 4.08% | Operating Margin (TTM) 5.31% |
Management Effectiveness
Return on Assets (TTM) 4.66% | Return on Equity (TTM) 13.38% |
Valuation
Trailing PE 28.13 | Forward PE 19.49 | Enterprise Value 5.55B | Price to Sales(TTM) 1.12 |
Enterprise Value 5.55B | Price to Sales(TTM) 1.12 | ||
Enterprise Value to Revenue 1.12 | Enterprise Value to EBITDA 16.42 | Shares Outstanding 26.65M | Shares Floating 26.25M |
Shares Outstanding 26.65M | Shares Floating 26.25M | ||
Percent Insiders 1.59 | Percent Institutions 102.4 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

